Page last updated: 2024-12-05
methyl 4-toluene sulfonate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
methyl 4-toluene sulfonate: catalyst in dental impression; material Scutan causing contact dermatitis; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 6645 |
| CHEMBL ID | 5189891 |
| SCHEMBL ID | 27524 |
| MeSH ID | M0062362 |
Synonyms (94)
| Synonym |
|---|
| methyl 4-methylbenzene-1-sulfonate |
| EN300-15726 |
| benzenesulfonic acid, 4-methyl-, methyl ester |
| p-methylbenzenesulfonate methyl ester |
| methyl tosylate |
| methyl 4-methylbenzenesulfonate |
| p-toluenesulfonic acid, methyl ester |
| methylester kyseliny p-toluensulfonove |
| p-toluenesulfonic acid methyl ester |
| wln: 1oswr d1 |
| methyl-p-toluenesulfonate |
| nsc-406335 |
| methyl p-toluenesulfonate |
| methyl toluenesulfonate |
| nsc406335 |
| methyl p-tosylate |
| p-toluolsulfonsaeure methyl ester |
| 80-48-8 |
| methyl toluene-4-sulfonate |
| ortho-toluenesulfonic acid, methyl ester |
| methyl p-toluenesulfonate, 98% |
| ccris 9151 |
| hsdb 2025 |
| brn 0609209 |
| methyl 4-toluene sulfonate |
| methylester kyseliny p-toluensulfonove [czech] |
| ai3-02550 |
| methyl toluene-4-sulphonate |
| einecs 201-283-5 |
| 4-toluenesulfonic acid, methyl ester |
| nsc 406335 |
| p-toluolsulfonsaeure methyl ester [german] |
| methyl p-methylbenzenesulfonate |
| methyl toluene sulfonate |
| FT-0695834 |
| T0269 |
| A839928 |
| 4-methyl-benzenesulfonic acid methyl ester |
| AM804364 |
| methyl 4-toluenesulfonate |
| AKOS008938769 |
| 4su69ki68l , |
| unii-4su69ki68l |
| 4-11-00-00247 (beilstein handbook reference) |
| FT-0619531 |
| methyl 4-methylbenzenesulphonate |
| methyl-p-toluensulfonate |
| methyl para-toluenesulphonate |
| paratoluen sulphonate methyl ester |
| methyl-paratoluene sulphonate |
| methyl rho-toluenesulfonate |
| methyl para-toluene sulfonate |
| methyl para-toluenesulfonate |
| methyltosylate |
| tsome |
| methyl-4-methylbenzenesulfonate |
| methyl-p-toluenesulphonate |
| tosylate methyl ester |
| p-toluene sulfonic acid methyl ester |
| methyl p-toluene-sulfonate |
| methyl tosylat |
| methyl p-toluene sulphonate |
| methyl paratoluenesulfonate |
| methyl p-toluenesulphonate |
| meots |
| methyl-4-toluene sulphonate |
| toluene-4-sulfonic acid-methyl ester |
| p-toluene-sulphonic acid methyl ester |
| SCHEMBL27524 |
| methyl 4-toluene sulfonate [hsdb] |
| p-methylbenzenesulfonic acid methyl ester |
| toluene-4-sulfonic acid methyl ester |
| NCGC00357078-01 |
| cas-80-48-8 |
| dtxcid1031123 |
| dtxsid4052550 , |
| tox21_303790 |
| Q-200515 |
| STR01542 |
| methyl ester of 4-methylbenzenesulfonic acid |
| methyl-(4)-toluenesulfonate |
| F0001-2085 |
| methyl p-toluenesulfonate, purum, >=97.0% (gc) |
| mfcd00008417 |
| CHEMBL5189891 |
| tosome |
| CS-0015899 |
| Q25616437 |
| methyl-4-toluene sulfonate |
| mfcd00069406 |
| D72514 |
| methyl-d3 4-methylbenzenesulfonate |
| SY276580 |
| methyl-13c,d3toluenesulfonate |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Protein Targets (1)
Potency Measurements
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| GLI family zinc finger 3 | Homo sapiens (human) | Potency | 6.8590 | 0.0007 | 14.5928 | 83.7951 | AID1259369 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
Bioassays (1)
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1852941 | Inhibition of human PHPT1 expressed in Escherichia coli BL21 (DE3) using pNPP as substrate at 25 uM incubated for 1 hr by multimode microplate reader analysis | 2022 | ACS medicinal chemistry letters, Dec-08, Volume: 13, Issue:12 | Identification of a Target Site for Covalent Inhibition of Protein Phosphohistidine Phosphatase 1. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
Research
Studies (10)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.40
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.40) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 10 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||